Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carl Anthony Evans Insider Profile
4 Followers
Carl Anthony Evans, Director at CNS Pharmaceuticals, holds 33.46K shares in CNS Pharmaceuticals (Ticker: CNSP). Most recently, Carl Anthony Evans Bought $33,333 shares of CNS Pharmaceuticals on Feb 06, 2024 for an estimated value of 10.00K.
Carl Anthony Evans has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Carl Anthony Evans's holdings
Insider Roles
Director
Roles that Carl Anthony Evans holds in companies
Most Profitable Insider Trade
The most profitable trade made by Carl Anthony Evans
Carl Anthony Evans's Trading History
List of latest transactions for each holding click on a transaction to see Carl Anthony Evans's performance on stock
You May Also Like
Carl Anthony Evans insider profile FAQ
What is the percentage of profitable transactions made by Carl Anthony Evans?
The percentage of profitable transactions made by Carl Anthony Evans is ―.
What is the average return per transaction made by Carl Anthony Evans?
The average return per transaction made by Carl Anthony Evans is ―.
What stocks does Carl Anthony Evans hold?
Carl Anthony Evans holds: CNSP stocks.
What was Carl Anthony Evans’s latest transaction?
Carl Anthony Evans latest transaction was an Informative Buy of $10.00K.
What was Carl Anthony Evans's most profitable transaction?
Carl Anthony Evans’s most profitable transaction was an Informative Buy of CNSP stock on February 6, 2024. The return on the trade was -20.30%.
What is Carl Anthony Evans's role in CNS Pharmaceuticals?
Carl Anthony Evans's role in CNS Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.